AwardedCzechiaGoodsCZK 170,616,000
Dodávky léků – Adalimumab 2026
- Published
- Published 24 April 2026
- Deadline
- Closed 29 May 2026
Overview
The Rheumatology Institute procured ongoing supplies of adalimumab (L04AB04) pharmaceutical preparation. The contract was awarded on June 9, 2026, to Avenier a.s. and PROMEDICA PRAHA GROUP, a.s., for a total value of 143,390,000 CZK against an estimated budget of 170,616,000 CZK.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 170,616,000
- Procedure
- Open
- Published
- 24 April 2026
- Deadline
- Closed
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- CZK 143,390,000
- Award date
- 9 June 2026
- Contract period
- — → 24 May 2029
- Avenier a.s.
- PROMEDICA PRAHA GROUP, a.s.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
20 July 2026
Contract Notice
24 April 2026
Contracting authority
Revmatologický ústav
Procuring entityPraha, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.